VIKPro’s Antarctic krill oil is now IKOS certified
IKOS is a voluntary and subscription-based service from Nutrasource that tests and verifies products by lot, through direct analysis, for omega-3, astaxanthin and phospholipid content, as well as environmental contaminants and freshness.
Photo © iStockphoto.com/volk65
VIKPro has achieved IKOS (International Krill Oil Standards) product certification for its branded Antarctic Krill Oil, according to an announcement from SGS Nutrasource Pharmaceutical and Nutraceutical Services Inc. (Guelph, ON, Canada). The only third-party testing and product certification program exclusively for krill oil, IKOS is a voluntary and subscription-based services that tests and verifies products by lot, through direct analysis, for omega-3, astaxanthin and phospholipid content, as well as environmental contaminants and freshness.
"Receiving the prestigious IKOS product certification is a testament to VIKPro’s unwavering commitment to delivering the highest quality krill oil to Chinese consumers. With IKOS' stringent assessment standards, we offer transparency, purity, and product excellence. This product certification boosts consumer trust, ensuring they make informed choices for their health,” said Wang Jiang Lei, director of marketing for VIK Pro, in a press release. “The communication process with Nutrasource has been exceptional with their response to the various requirements in the fastest time, with accurate and reliable testing results.”
"We are thrilled that VikPro, a leading krill oil supplement brand in China, has been awarded their second IKOS product certification for the VIKMed Antarctic Krill Oil softgels. Krill oil promises numerous health benefits, and VikPro's successful certification under the IKOS program reflects excellent product quality and transparency for their Chinese consumers. Nutrasource is committed to supporting the growth of krill oil products in China," added Hyun-Ah Kim, IKOS program manager.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
